✦ LIBER ✦

Suppression of ovarian steroidogenesis by zoladex in postmenopausal breast cancer patients

✍ Scribed by M. Dowsett; B.M.J. Cantwell; A. Lal; S.L. jeffcoate; A.L. Harris

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of LH-RH agonist zoladex in postmeno

✍ A.L. Harris; B.M.J. Cantwell; J. Carmichael; J. Farndon; R. Wilson; M. Dowsett 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Ovarian Tumors in Postmenopausal Breast

✍ Ilan Cohen; Yoram Beyth; Ron Tepper; Jeremiah Shapira; Yaron Zalel; Arie Figer; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Ovarian Volume in Postmenopausal Breast

✍ Ilan Cohen; Marco M. Altaras; Yoram Beyth; Yaron Zalel; Jeremiah Shapira; Dror Y 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 62 KB

SUPPRESSION OF PLASMA ANDROGENS BY THE A

✍ M. AYUB; M. J. LEVELL 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 718 KB

P06.15: Ovarian hyperstimulation by Tamo

✍ S. Pinheiro; P. Timmons; C. Verdeza; R. Rozhavskaya 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Ovarian ablation (OO) versus zoladex (Z)

✍ Boccardo, F.; Rubagotti, A.; Amoroso, D.; De Mattesis, A.; Di Cario, A.; Galligi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 164 KB